Pharma

All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Guleria said an effective Covid-19 vaccine can be expected in India by January 2021 if everything goes as planned. Speaking during a session of the India Today Healthgiri Awards 2020, Guleria admitted that it is hard to say when a vaccine will be available in the country and that it...

US biotech firm Moderna won't seek an emergency use authorization for its coronavirus vaccine before November 25, its CEO told the Financial Times on Wednesday. The news deals a blow to President Donald Trump's hopes of having an injection ready before the election to give his campaign a much-needed boost. Stephane Bancel told the newspaper: "November 25 is the time we...

The Union Health Ministry has said it does not agree with the ₹ 80,000 crore figure cited by Adar Poonawalla, CEO of Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting trials of Covid vaccine candidates ahead of mass production - for buying and distributing the vaccine in the country. The...

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published on Friday. The vaccine, called Ad26.COV2.S, was equally well-tolerated at two different doses, the results showed. A single shot, versus a rival two-dose approach being tested by Moderna Inc and...

India has reported the highest rate of coronavirus recoveries in the world, which has crossed the 80 per cent-mark, said Union Health Ministry today. Addressing the Health Ministry press briefing on the COVID-19 situation, Rajesh Bhushan, Secretary, Union Health Ministry said, "We get swayed by the narrative that India has over 50 lakh cases, but we forget that nearly 45...

The Supreme Court on Wednesday said there was an approval by the Central government on use of Remdesivir and Fabiparivir as medicines to treat COVID-19. The top court was hearing a plea seeking registration of an FIR by the CBI against ten Indian pharmaceutical firms for manufacturing and selling these two medicines for treating COVID-19 patients allegedly without...

Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the China Centre for Disease Control and Prevention (CDC) said. China has four COVID-19 vaccines in the final stage of clinical trials. At least three of those have already been offered to essential workers under an emergency...

Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phrase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in the UK...

India, a global hub for generic drugs, has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain, according to NITI Aayog CEO Amitabh Kant. Speaking at the 14th Annual BioPharma and Healthcare Summit, he said India is now gearing up for innovation in its pharmaceutical ecosystem focusing on...

Drug firm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium Besylate Injection, a muscle relaxant given before general anaesthesia. Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Cisatracurium Besylate Injection USP in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial, Cadila Healthcare...